These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1731208)

  • 1. Combating counterfeit drugs.
    Land T
    Nature; 1992 Jan; 355(6357):192. PubMed ID: 1731208
    [No Abstract]   [Full Text] [Related]  

  • 2. Deterring the importation of counterfeit pharmaceutical products.
    Stearn DW
    Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351
    [No Abstract]   [Full Text] [Related]  

  • 3. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counterfeit drugs: defining the problem and finding solutions.
    Wertheimer AI; Santella TM
    Expert Opin Drug Saf; 2005 Jul; 4(4):619-22. PubMed ID: 16011440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WHO wants safer medicines for children.
    Choonara I
    Arch Dis Child; 2008 Jun; 93(6):456-7. PubMed ID: 18495908
    [No Abstract]   [Full Text] [Related]  

  • 6. WHO tries to tackle problem of counterfeit medicines in Asia.
    Pincock S
    BMJ; 2003 Nov; 327(7424):1126. PubMed ID: 14615319
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drugs in the 3d World. Every profession has its share of responsibility].
    Rosenkvist I
    Sygeplejersken; 1983 Jun; 83(21):24-6. PubMed ID: 6555952
    [No Abstract]   [Full Text] [Related]  

  • 8. Are rich nations up for drug reform?
    Check E
    Nature; 2006 May; 441(7090):135. PubMed ID: 16688137
    [No Abstract]   [Full Text] [Related]  

  • 9. [Counterfeit and fake drugs: medications that kill].
    Ambroise-Thomas P
    Med Trop (Mars); 2010 Jun; 70(3):213-4. PubMed ID: 20734583
    [No Abstract]   [Full Text] [Related]  

  • 10. Combating counterfeit drugs.
    Lancet; 2008 May; 371(9624):1551. PubMed ID: 18468523
    [No Abstract]   [Full Text] [Related]  

  • 11. [Counterfeit drugs in Israel and worldwide. Part I: the extent of occurrence and impending threats].
    Tamir O; Friedman N; Furman-Assaf S; Marom E; Arieli M; Shemer J
    Harefuah; 2010 Jul; 149(7):466-9, 479. PubMed ID: 21465763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO and industry combine to form ethics body.
    Dickson D
    Nat Med; 2002 Jul; 8(7):645. PubMed ID: 12091885
    [No Abstract]   [Full Text] [Related]  

  • 13. New countermeasures considered as drug counterfeiting grows.
    Schubert C
    Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
    [No Abstract]   [Full Text] [Related]  

  • 14. The World Health Organization's prequalification program and its potential effect on data exclusivity laws.
    Childs DW
    Food Drug Law J; 2005; 60(1):79-97. PubMed ID: 15940855
    [No Abstract]   [Full Text] [Related]  

  • 15. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
    Berger JM
    Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
    [No Abstract]   [Full Text] [Related]  

  • 16. Substandard medicines in resource-poor settings: a problem that can no longer be ignored.
    Caudron JM; Ford N; Henkens M; Macé C; Kiddle-Monroe R; Pinel J
    Trop Med Int Health; 2008 Aug; 13(8):1062-72. PubMed ID: 18631318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counterfeit drugs: implications for health.
    ten Ham M
    Adverse Drug React Toxicol Rev; 1992; 11(1):59-65. PubMed ID: 1606284
    [No Abstract]   [Full Text] [Related]  

  • 18. [On misery coast. Episode 1: the market of vital drugs].
    Chneiweiss H
    Med Sci (Paris); 2003; 19(8-9):892-4. PubMed ID: 14593623
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quality of medicines in least developed countries].
    Videau JY
    Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of pharmaceutical product diversion and the gray market: cheaper drugs, but at what cost?
    Dooley K; Sullivan JA
    Health Care Law Mon; 2010 Oct; 2010(10):2-8. PubMed ID: 21302589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.